Sun Pharma gets regulatory nod to sell generic Wegovy in India
The drugmaker will launch generic semaglutide, the active ingredient in Novo Nordisk's drugs Wegovy andOzempic, in India under the brand name Noveltreat, once the semaglutide patent expires in March 2026